Allianz Asset Management GmbH lessened its stake in Dolby Laboratories (NYSE:DLB) by 7.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 200,915 shares of the electronics maker’s stock after selling 16,722 shares during the quarter. Allianz Asset Management GmbH owned 0.20% of Dolby Laboratories worth $11,557,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of the company. Envestnet Asset Management Inc. raised its holdings in Dolby Laboratories by 11.1% in the 3rd quarter. Envestnet Asset Management Inc. now owns 22,440 shares of the electronics maker’s stock worth $1,292,000 after purchasing an additional 2,242 shares during the period. Convergence Investment Partners LLC acquired a new position in Dolby Laboratories in the 3rd quarter worth about $1,824,000. Stifel Financial Corp raised its holdings in Dolby Laboratories by 28.2% in the 3rd quarter. Stifel Financial Corp now owns 84,728 shares of the electronics maker’s stock worth $4,868,000 after purchasing an additional 18,626 shares during the period. Trigran Investments Inc. raised its holdings in Dolby Laboratories by 59.0% in the 3rd quarter. Trigran Investments Inc. now owns 178,621 shares of the electronics maker’s stock worth $10,274,000 after purchasing an additional 66,247 shares during the period. Finally, BB&T Securities LLC raised its holdings in Dolby Laboratories by 6.4% in the 3rd quarter. BB&T Securities LLC now owns 16,749 shares of the electronics maker’s stock worth $963,000 after purchasing an additional 1,003 shares during the period. 52.53% of the stock is owned by institutional investors and hedge funds.
In other Dolby Laboratories news, CMO Bob Borchers sold 50,000 shares of the stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $62.72, for a total transaction of $3,136,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Steven E. Forshay sold 9,355 shares of the stock in a transaction that occurred on Monday, October 30th. The shares were sold at an average price of $57.86, for a total value of $541,280.30. The disclosure for this sale can be found here. Insiders have sold 511,095 shares of company stock valued at $31,288,813 in the last three months. Insiders own 43.80% of the company’s stock.
Dolby Laboratories (NYSE DLB) opened at $62.32 on Friday. The firm has a market capitalization of $6,238.54, a PE ratio of 29.32, a P/E/G ratio of 2.26 and a beta of 0.86. Dolby Laboratories has a fifty-two week low of $44.98 and a fifty-two week high of $63.34.
Dolby Laboratories (NYSE:DLB) last announced its earnings results on Wednesday, October 25th. The electronics maker reported $0.45 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.18. Dolby Laboratories had a return on equity of 10.62% and a net margin of 18.66%. The business had revenue of $242.05 million during the quarter, compared to analysts’ expectations of $244.80 million. During the same quarter in the prior year, the firm earned $0.37 earnings per share. The business’s revenue was up 3.9% compared to the same quarter last year. research analysts predict that Dolby Laboratories will post 2.24 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “Allianz Asset Management GmbH Has $11.56 Million Stake in Dolby Laboratories (DLB)” was posted by Community Financial News and is owned by of Community Financial News. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.com-unik.info/2017/12/16/allianz-asset-management-gmbh-has-11-56-million-stake-in-dolby-laboratories-dlb.html.
Dolby Laboratories Profile
Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.
What are top analysts saying about Dolby Laboratories? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Dolby Laboratories and related companies.